HBY 097

Known as: HBY-097 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2008
01219952008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Clinically relevant Lys103Asn (K103N) mutant frequently observed in HIV-1 reverse transcriptase (RT) confers drug resistance. To… (More)
Is this relevant?
2001
2001
Inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT) are widely used in the treatment of HIV infection… (More)
Is this relevant?
1999
1999
HBY-097 (HBY), an investigational nonnucleoside reverse transcriptase inhibitor (NNRTI), and indinavir (IDV) share a common… (More)
Is this relevant?
1999
1999
The safety and antiviral activity of the second-generation nonnucleoside inhibitor HBY 097 was investigated in asymptomatic or… (More)
Is this relevant?
1998
1998
The second generation Hoechst-Bayer non-nucleoside inhibitor, HBY 097 (S-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3, 4… (More)
Is this relevant?
1998
1998
Human immunodeficiency virus type 1 (HIV-1) strains resistant to nonnucleoside reverse transcriptase inhibitors (NNRTIs) may… (More)
Is this relevant?
1998
1998
Two HPLC methods were developed: one for the quantitation of HBY 097 reverse transcriptase inhibitor and its metabolites M2 and… (More)
Is this relevant?
1997
1997
In vitro resistance of HIV-1 against high levels of HBY 097 ((S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3, 4-dihydro… (More)
Is this relevant?
1996
1996
The quinoxaline nonnucleoside RT inhibitor (NNRTI) (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
1995
1995
HBY 097 [(S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3, 4-dihydroquinoxaline-2(1H)-thione] was selected from a series… (More)
Is this relevant?